SCHEMBL17206355

SCHEMBL17206355

BrCn1ccc(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
KDM4E B2RXH2 5/20 0.45
RAB9A P51151 4/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 4/20 0.45
NPC1 O15118 4/20 0.45
LMNA P02545 3/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP19A1 P11511 1/20 0.37
MEN1 O00255 3/20 0.37
HSD17B10 Q99714 2/20 0.36
KCNJ6 P48051 1/20 0.36
KCNJ5 P48544 1/20 0.36
KCNJ3 P48549 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13792157 0.80 KMT2A (0.53) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL11123118 0.80 KMT2A (0.59) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL2187295 0.80 KMT2A (0.53) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL10277534 0.78 KMT2A (0.52) KMT2AKDM4ERAB9AALDH1A1HPGD
Hydrochloric Acid SCHEMBL2188431 0.78 KMT2A (0.52) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL7494123 0.78 RAB9A (0.68) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL15338801 0.77 KMT2A (0.60) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL6917539 0.77 KMT2A (0.55) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL9384038 0.77 KMT2A (0.55) KMT2AKDM4ERAB9AALDH1A1HPGD
SCHEMBL15338798 0.76 KMT2A (0.48) KMT2AKDM4ERAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134386-A1 ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE Takeda Pharmaceutical Company Limited (JP) 2017-03-01 EP disclosed
WO-2015163485-A1 ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-10-29 WO disclosed